Trastuzumab

Records for this ingredient, by country (identity only).

ATC L01FD01 · 13 markets · 333 records

Trastuzumab 13 markets · 333 records Forms
Filters
MarketGB 160AU 27ES 21CA 17FR 16TW 15EU 13US 12SG 11CN 11HK 11JP 7MX 6
Kind

GB 160 records · 14 shown of 30 Source NHSBSA dm+d · Data as of 2026-10-19

Only this ingredient

  • 150 mg per mL / per unit basis not statedinjectionHerceptin 150mg powder for concentrate for solution for infusion vialsHerzuma 150mg powder for concentrate for solution for infusion vials、Kanjinti 150mg powder for concentrate for solution for infusion vials、Ogivri 420mg powder for concentrate for solution for infusion vials、Ontruzant 150mg powder for concentrate for solution for infusion vials、Trazimera 150mg powder for concentrate for solution for infusion vials、Zercepac 150mg powder for concentrate for solution for infusion vials
  • 420 mg per mL / per unit basis not statedinjectionHerzuma 150mg powder for concentrate for solution for infusion vialsKanjinti 150mg powder for concentrate for solution for infusion vials、Ogivri 420mg powder for concentrate for solution for infusion vials、Trazimera 150mg powder for concentrate for solution for infusion vials、Zercepac 150mg powder for concentrate for solution for infusion vials
  • 1,323 mg/250 mLinjectionTrastuzumab (Herceptin) 42mg/250ml in Sodium chloride 0.9% infusion bagsTrastuzumab (Herzuma) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Kanjinti) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Ontruzant) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Trazimera) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Zercepac) 42mg/250ml in Sodium chloride 0.9% infusion bags
  • 1,176 mg/250 mLinjectionTrastuzumab (Herceptin) 42mg/250ml in Sodium chloride 0.9% infusion bagsTrastuzumab (Herzuma) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Kanjinti) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Ontruzant) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Trazimera) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Zercepac) 42mg/250ml in Sodium chloride 0.9% infusion bags
  • 1,029 mg/250 mLinjectionTrastuzumab (Herceptin) 42mg/250ml in Sodium chloride 0.9% infusion bagsTrastuzumab (Herzuma) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Kanjinti) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Ontruzant) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Trazimera) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Zercepac) 42mg/250ml in Sodium chloride 0.9% infusion bags
  • 882 mg/250 mLinjectionTrastuzumab (Herceptin) 42mg/250ml in Sodium chloride 0.9% infusion bagsTrastuzumab (Herzuma) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Kanjinti) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Ontruzant) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Trazimera) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Zercepac) 42mg/250ml in Sodium chloride 0.9% infusion bags
  • 735 mg/250 mLinjectionTrastuzumab (Herceptin) 42mg/250ml in Sodium chloride 0.9% infusion bagsTrastuzumab (Herzuma) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Kanjinti) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Ontruzant) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Trazimera) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Zercepac) 42mg/250ml in Sodium chloride 0.9% infusion bags
  • 651 mg/250 mLinjectionTrastuzumab (Herceptin) 42mg/250ml in Sodium chloride 0.9% infusion bagsTrastuzumab (Herzuma) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Kanjinti) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Ontruzant) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Trazimera) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Zercepac) 42mg/250ml in Sodium chloride 0.9% infusion bags
  • 588 mg/250 mLinjectionTrastuzumab (Herceptin) 42mg/250ml in Sodium chloride 0.9% infusion bagsTrastuzumab (Herzuma) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Kanjinti) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Ontruzant) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Trazimera) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Zercepac) 42mg/250ml in Sodium chloride 0.9% infusion bags
  • 504 mg/250 mLinjectionTrastuzumab (Herceptin) 42mg/250ml in Sodium chloride 0.9% infusion bagsTrastuzumab (Herzuma) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Kanjinti) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Ontruzant) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Trazimera) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Zercepac) 42mg/250ml in Sodium chloride 0.9% infusion bags
  • 441 mg/250 mLinjectionTrastuzumab (Herceptin) 42mg/250ml in Sodium chloride 0.9% infusion bagsTrastuzumab (Herzuma) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Kanjinti) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Ontruzant) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Trazimera) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Zercepac) 42mg/250ml in Sodium chloride 0.9% infusion bags
  • 378 mg/250 mLinjectionTrastuzumab (Herceptin) 42mg/250ml in Sodium chloride 0.9% infusion bagsTrastuzumab (Herzuma) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Kanjinti) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Ontruzant) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Trazimera) 42mg/250ml in Sodium chloride 0.9% infusion bags、Trastuzumab (Zercepac) 42mg/250ml in Sodium chloride 0.9% infusion bags
Other strengths: 16 · 1 dosage forms Otras concentraciones: 16 · 1 formas farmacéuticas 其余规格 16 个 · 涉及 1 种剂型 其餘規格 16 個 · 涉及 1 種劑型 · 336 mg/250 mL、294 mg/250 mL、252 mg/250 mL、210 mg/250 mL、176.4 mg/250 mL、147 mg/250 mL、126 mg/250 mL、105 mg/250 mL、88.2 mg/250 mL、75.6 mg/250 mL、63 mg/250 mL、54.6 mg/250 mL、46.2 mg/250 mL、42 mg/250 mL、600 mg/5 mL
injection · 16336 mg/250 mL294 mg/250 mL252 mg/250 mL210 mg/250 mL176.4 mg/250 mL147 mg/250 mL126 mg/250 mL105 mg/250 mL88.2 mg/250 mL75.6 mg/250 mL This form has 6 more Esta forma tiene 6 más 该剂型还有 6 个 該劑型還有 6 個

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Combination products containing this ingredient

AU 27 records · 13 shown of 13 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Only this ingredient

  • 150 mg per mL / per unit basis not statedinjectionHERZUMAHERZUMA trastuzumab (rch) 150 mg powder for injection for intravenous infusion vial、OGIVRI、ONTRUZANT trastuzumab 150 mg powder for injection vial、TRASTUCIP trastuzumab 150 mg powder for injection vial、Trazimera、TRAZIMERA trastuzumab 60 mg powder for injection vial、TUZUCIP trastuzumab 150 mg powder for injection vial unknown
  • 420 mg per mL / per unit basis not statedinjectionKanjinti
  • 440 mg per mL / per unit basis not statedinjectionHERZUMAKANJINTI trastuzumab 150 mg powder for injection vial unknown
  • 150 mgpowderOGIVRI trastuzumab (rch) 150 mg powder for injection vial also in CA unknown
  • 60 mg per mL / per unit basis not statedinjectionTrazimeraTRAZIMERA trastuzumab 60 mg powder for injection vial unknown
  • 600 mg/5 mLinjectionHerceptin SC also in GB·ES·FR
  • 440 mgpowderOGIVRI trastuzumab (rch) 440 mg powder for injection vial with bacteriostatic water for injection also in CA unknown
  • 600 mg per mL / per unit basis not statedinjectionHERCEPTIN SC trastuzumab (rch) 600mg/5mL solution for unknown
  • 156 mg per mL / per unit basis not statedinjectionKANJINTI trastuzumab 150 mg powder for injection vial unknown
  • 65 mg per mL / per unit basis not statedinjectionKANJINTI trastuzumab 150 mg powder for injection vial unknown
  • 440 mgunknownHERZUMA trastuzumab (rch) 440 mg powder for injection for intravenous infusion vial with diluent unknown

Combination products containing this ingredient

  • 600 mg per mL / per unit basis not statedinjection CombinationPertuzumab 1,200 mg + Trastuzumab 600 mg + Water For Injections 15 mLPHESGO SC pertuzumab (rch) 1200mg and trastuzumab (rch) 600mg in 15mL solution for injection, vials unknown
  • 600 mg per mL / per unit basis not statedinjection CombinationPertuzumab 600 mg + Trastuzumab 600 mg + Water For Injections 10 mLPHESGO SC pertuzumab (rch) 1200mg and trastuzumab (rch) 600mg in 15mL solution for injection, vials unknown
5 records · 0 manufacturers 5 registros · 0 fabricantes 5 个记录 · 0 个厂家 5 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Herceptin SC ×2HERZUMA ×2Kanjinti ×2OGIVRI ×4Trazimera ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

ES 21 records · 6 shown of 6 Source CIMA (AEMPS) · Data as of live · some records have no stated strength

Only this ingredient

  • 150 mg per mL / per unit basis not statedinjectionHerceptinHERZUMA、OGIVRI、Ontruzant、Trazimera、ZERCEPAC
  • 420 mg per mL / per unit basis not statedinjectionHERZUMAKanjinti、OGIVRI、Ontruzant、Trazimera、ZERCEPAC
  • 600 mg/5 mLinjectionHerceptin also in GB·AU·FR
  • 21 mg/1 mLinjectionKanjinti

Combination products containing this ingredient

  • 600 mg per mL / per unit basis not statedinjection CombinationPertuzumab 1,200 mg + Trastuzumab 600 mgPhesgo
  • 600 mg per mL / per unit basis not statedinjection CombinationPertuzumab 600 mg + Trastuzumab 600 mgPhesgo
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Phesgo ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

CA 17 records · 9 shown of 9 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Only this ingredient

  • 150 mgpowderADHEROZAHERZUMA、Kanjinti、OGIVRI、Ontruzant、Trazimera also in AU
  • 440 mgpowderHerceptinOntruzant、Trazimera also in AU
  • 420 mg per mL / per unit basis not statedliquidADHEROZAKanjinti
  • 440 mg per mL / per unit basis not statedliquidHERZUMA
  • 120 mg/1 mLliquidHerceptin SC

Combination products containing this ingredient

  • 440 mg per mL / per unit basis not statedliquid CombinationPertuzumab 30 mg/1 mL + Trastuzumab 440 mgPERJETA-HERCEPTIN
  • 60 mg per mL / per unit basis not statedliquid CombinationPertuzumab 60 mg + Trastuzumab 60 mgPhesgo
  • 40 mg per mL / per unit basis not statedliquid CombinationPertuzumab 80 mg + Trastuzumab 40 mgPhesgo
  • 440 mgpowder CombinationTrastuzumab 440 mg + Water 20 mLOGIVRI

FR 16 records · 5 shown of 5 Source Base de données publique des médic · Data as of 2026-11-03

Only this ingredient

  • 150 mg per mL / per unit basis not statedinjectionHERCEPTIN 150 mg, poudre pour solution à diluer pour perfusionHERZUMA 150 mg, poudre pour solution à diluer pour perfusion、KANJINTI 150 mg, poudre pour solution à diluer pour perfusion、OGIVRI 150 mg, poudre pour solution à diluer pour perfusion、ONTRUZANT 150 mg, poudre pour solution à diluer pour perfusion、TRAZIMERA 150 mg, poudre pour solution à diluer pour perfusion、ZERCEPAC 150 mg, poudre pour solution à diluer pour perfusion
  • 420 mg per mL / per unit basis not statedinjectionHERZUMA 150 mg, poudre pour solution à diluer pour perfusionKANJINTI 150 mg, poudre pour solution à diluer pour perfusion、OGIVRI 150 mg, poudre pour solution à diluer pour perfusion、ONTRUZANT 150 mg, poudre pour solution à diluer pour perfusion、TRAZIMERA 150 mg, poudre pour solution à diluer pour perfusion、ZERCEPAC 150 mg, poudre pour solution à diluer pour perfusion
  • 600 mg/5 mLinjectionHERCEPTIN 600 mg, solution injectable en flacon also in GB·AU·ES

Combination products containing this ingredient

TW 15 records · 3 shown of 3 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

Only this ingredient

  • 150 mg per mL / per unit basis not statedinjectionEirgasun vial 150 mgHERCEPTIN VIAL 150MG、Herzuma Inj. 150mg, Lyophilized powder for injection、KANJINTI Powder for concentrate for solution for infusion 420mg、OGIVRI、Trazimera Powder for Concentrate for Solution for infusion 150 mg、康癌停凍晶注射劑150毫克、曲斯若凍晶注射劑150毫克、癌吉清凍晶注射劑150毫克 +3
  • 420 mg per mL / per unit basis not statedinjectionEirgasun vial 150 mgKANJINTI Powder for concentrate for solution for infusion 420mg、康癌停凍晶注射劑420毫克、益康平凍晶注射劑 420 毫克
  • 440 mg per mL / per unit basis not statedinjectionHERCEPTIN VIAL 150MGHerzuma Inj. 150mg, Lyophilized powder for injection、OGIVRI、Trazimera Powder for Concentrate for Solution for infusion 150 mg、曲斯若凍晶注射劑440毫克、癌吉清凍晶注射劑440毫克、賀癌平 凍晶注射劑440毫克、赫珠瑪 凍晶注射劑440毫克
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Herceptin solution for injection ×2Phesgo Solution for Subcutaneous Injection 1200/600 mg ×8賀癌平 皮下注射劑 ×1賀雙妥皮下注射劑 1200/600毫克 ×1賀雙妥皮下注射劑 600/600毫克 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

EU 13 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength · includes records with unknown status (not proof of sale)

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

13 records · 0 manufacturers 13 registros · 0 fabricantes 13 个记录 · 0 个厂家 13 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Dazublys ×1Herceptin ×2Hervelous ×1Herwenda ×1HERZUMA ×2Kanjinti ×2OGIVRI ×4Ontruzant ×2

and 4 more (0 manufacturers) y 4 más (0 fabricantes) 还有 4 个（0 个厂家） 還有 4 個（0 個廠商）

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

US 12 records · 7 shown of 7 Source openFDA NDC Directory · Data as of 2026-10-23

Only this ingredient

  • 150 mg per mL / per unit basis not statedinjectionOntruzant
  • 150 mg/7.15 mLinjectionHERZUMAKanjinti、Trazimera
  • 420 mg/20 mLinjectionKanjintiOGIVRI
  • 150 mg/7.4 mLinjectionHerceptinOGIVRI

Combination products containing this ingredient

  • 600 mg/5 mLinjection CombinationHyaluronidase (Human Recombinant) 10,000 unit/5 mL + Trastuzumab 600 mg/5 mLHerceptin Hylecta
  • 600 mg/10 mLinjection CombinationHyaluronidase (Human Recombinant) 20,000 unit/10 mL + Pertuzumab 600 mg/10 mL + Trastuzumab 600 mg/10 mLPhesgo
  • 600 mg/15 mLinjection CombinationHyaluronidase (Human Recombinant) 30,000 unit/15 mL + Pertuzumab 1,200 mg/15 mL + Trastuzumab 600 mg/15 mLPhesgo

SG 11 records · 7 shown of 7 Source Health Sciences Authority (HSA) · Data as of 2026-08-07 · some records have no stated strength

Only this ingredient

Combination products containing this ingredient

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名TRAZHER (Trastuzumab) Powder for Concentrate for Solution for Infusion 60mg/vial ×3

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

CN 11 records · 4 shown of 4 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

Only this ingredient

  • 150 mg per mL / per unit basis not statedinjection安曲妥曲妥珠单抗安瑞泽、安赛汀、汉曲优、赛妥
  • 440 mg per mL / per unit basis not statedinjection赫赛汀曲妥珠单抗
  • 60 mg per mL / per unit basis not statedinjection汉曲优曲妥珠单抗
  • 600 mg per mL / per unit basis not statedinjectionManufacturer: Roche Pharma(Schweiz) AG

HK 11 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

11 records · 0 manufacturers 11 registros · 0 fabricantes 11 个记录 · 0 个厂家 11 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名HERCEPTIN POWDER & SOLVENT FOR INJ 440MG ×1HERCEPTIN POWDER AND SOLVENT FOR INJECTION 440MG ×1HERCEPTIN POWDER FOR INJ 150MG ×2HERCEPTIN SOLUTION FOR INJECTION 600MG/5ML (FOR SUBCUTANEOUS USE ONLY) ×1HERZUMA POWDER AND SOLVENT FOR CONCENTRATE FOR SOLUTION FOR INFUSION 420MG ×1HERZUMA® 440MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION ×3KANJINTI POWDER AND SOLVENT FOR CONCENTRATE FOR SOLUTION FOR INFUSION 420MG ×1KANJINTI Powder for concentrate for solution for infusion 420mg ×3

and 1 more (0 manufacturers) y 1 más (0 fabricantes) 还有 1 个（0 个厂家） 還有 1 個（0 個廠商）

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

JP 7 records · 4 shown of 4 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

Only this ingredient

Combination products containing this ingredient

  • 15 mL per mL / per unit basis not statedinjection CombinationBerahyaluronidase Alfa 15 mL + Pertuzumab 15 mL + Trastuzumab 15 mLフェスゴ配合皮下注 IN
  • 10 mL per mL / per unit basis not statedinjection CombinationBerahyaluronidase Alfa 10 mL + Pertuzumab 10 mL + Trastuzumab 10 mLフェスゴ配合皮下注 MA

MX 6 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

6 records · 0 manufacturers 6 registros · 0 fabricantes 6 个记录 · 0 个厂家 6 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名HERZUMA ×2Kanjinti ×2MAMITRA ×1Phesgo ×2TRAZON ×1TUZEPTA ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Also called: 曲妥珠單抗、賀癌平 nickname

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.